Searched for
MOREPEN PROFIT
Mayuresh Joshi on his 2 top bets in pharma & what he likes in oil & gas sectorMayuresh Joshi from Marketsmith India shared insights on favored pharma stocks like Natco, Morepen, Cipla, and Dr Reddy's, emphasizing stro...- SC seeks response from govt regarding appointment of two directors on Morepen Labs' boardSeeking setting aside of the National Company Law Appellate Tribunal’s April 25 order that continued the erstwhile Company Law Board’s orde...
- Market Movers: Investors dump Nykaa shares ahead of earningsNykaa has faced massive selloff off late as Street dumped shares of richly valued new-age companies against the backdrop of Fed rate hikes,...
- Morepen Laboratories Q3 Results: Profit dips 10% to Rs 22 crNet revenue, however, rose to Rs 399.19 crore in the third quarter as compared with Rs 310.26 crore in the same period of 2020-21, Morepen ...
- Morepen Labs zooms 8% on USFDA nod to market anti-allergy drugThe US FDA approval provides an imminent boost to Morepen’s export business as Fexofenadine is a well-established anti-allergy drug boastin...
- Morepen Labs Q2 results: Net profit up 38% at Rs 37 crore"With massive increase in active pharmaceutical ingredient (API) demand globally and more particularly with frequent supply disruptions fro...
- Morepen Labs jumps 11% on transfer of medical devices biz to subsidiaryAccording to a BSE filing, Morepen Labs will transfer the medical equipment business to a wholly-owned subsidiary by allotment of equity sh...
- Morepen Laboratories Q1 results: Net profit jumps 57% to Rs 30 crIts net revenue stood at Rs 388.31 crore in the quarter under consideration, up 50 per cent against Rs 258.97 crore a year ago, Morepen Lab...
- 125% jump in a month, 360% in a year; safety rush turns this laggard a multibaggerThe smallcap pharma scrip has been thumping rock and roll over the past few weeks.
- Morepen Laboratories posts two-fold jump in Q4 profitThe drug firm's consolidated net profit came in at Rs 26.76 crore for the quarter ended March 31.
- Stocks in news: Reliance Inds, Hindustan Unilever, Titan, Bajaj Auto and Ambuja CementsHindustan Unilever, Titan and Bajaj Auto, Ambuja Cements, Motherson Sumi, Bajaj Holdings, Shriram Transport, AU SFB, IndiaMart InterMesh an...
- Stocks in the news: ICICI Bank, SBI Card, TechM, HDFC Life, HCL Tech and Morepen LabsHCL Technologies is engaging closely with clients to prioritise work, and shifting some workload from India to other geographies.
- Morepen Labs Q3 results: Net profit rises over two-fold to Rs 24 crConsolidated total revenue of the company stood at Rs 310.26 crore for the quarter under consideration. It was Rs 234.65 crore for the same...
- Morepen Labs Q2 results: Net profit jumps over 6-fold to Rs 27crTotal revenue stood at Rs 340.12 crore for the quarter under consideration. It was Rs 216.24 crore for the same period a year ago, it added.
- Morepen Labs Q1 results: Net profit jumps over two-fold to Rs 19.36 croreThe company had posted a net profit of Rs 7.65 crore in the corresponding period of previous fiscal, Morepen Laboratories said in a filing ...
- Trending stocks: Morepen Laboratories shares slip over 5%A total of 368,301 shares changed hands on the counter till 11:07AM (IST).
- Stocks in the news: RIL, Vodafone Idea, Asian Paints, Bharti Airtel, BoB and ONGCBerger Paints, Balrampur Chini, Bank of Baroda and Page Industries will unveil their March quarter earnings on Tuesday.
- Morepen Labs Q4 results: Net profit rises 5% to Rs 11 croreIts consolidated total revenue stood at Rs 208.38 crore for the quarter under consideration.
- Taro Q4 results spook pharma majors, shares tankSun pharma and Divi’s Labs settled lower by 3.17 per cent and 3.29 per cent, respectively.
- Morepen to sell anti-asthmatic drug Montelukast in Europe, North AmericaPharma firm Morepen Laboratories today said it is preparing to sell anti-asthmatic drug Montelukast in European and North American markets.
Load More
